Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 78

1.

Sublingual immunotherapy: A focused allergen immunotherapy practice parameter update.

Greenhawt M, Oppenheimer J, Nelson M, Nelson H, Lockey R, Lieberman P, Nowak-Wegrzyn A, Peters A, Collins C, Bernstein DI, Blessing-Moore J, Khan D, Lang D, Nicklas RA, Portnoy JM, Randolph CR, Schuller DE, Spector SL, Tilles SA, Wallace D.

Ann Allergy Asthma Immunol. 2017 Mar;118(3):276-282.e2. doi: 10.1016/j.anai.2016.12.009. No abstract available.

PMID:
28284533
2.

Sublingual immunotherapy in preschool children: an update.

Vitaliti G, Pavone P, Guglielmo F, Falsaperla R.

Expert Rev Clin Immunol. 2013 Apr;9(4):385-90. doi: 10.1586/eci.13.7. Review.

PMID:
23557273
3.

Sublingual allergen immunotherapy for respiratory allergies: what is new?

Makatsori M, Calderon MA.

Expert Rev Clin Immunol. 2014 Dec;10(12):1641-7. doi: 10.1586/1744666X.2014.982536. Review.

PMID:
25407099
4.

Selection of patients for sublingual versus subcutaneous immunotherapy.

Larenas Linnemann DE, Blaiss MS.

Immunotherapy. 2014;6(7):871-84. doi: 10.2217/imt.14.55. Review.

PMID:
25290418
5.

Allergen immunotherapy: what's new, what's next?

Nelson HS.

Expert Rev Clin Immunol. 2015;11(9):959-61. doi: 10.1586/1744666X.2015.1062726. Epub 2015 Jul 1.

PMID:
26134252
6.

Major allergen content consistency of SQ house dust mite sublingual immunotherapy tablets and relevance across geographic regions.

Nolte H, Plunkett G, Grosch K, Larsen JN, Lund K, Bollen M.

Ann Allergy Asthma Immunol. 2016 Sep;117(3):298-303. doi: 10.1016/j.anai.2016.07.004.

PMID:
27613464
7.

Sublingual Immunotherapy: A Useful Tool for the Allergist in Private Practice.

Saporta D.

Biomed Res Int. 2016;2016:9323804. doi: 10.1155/2016/9323804. Epub 2016 May 31. Review.

8.

Immunological mechanisms of sublingual immunotherapy.

Allam JP, Novak N.

Curr Opin Allergy Clin Immunol. 2014 Dec;14(6):564-9. doi: 10.1097/ACI.0000000000000118. Review.

PMID:
25233080
9.

Guiding principles of sublingual immunotherapy for allergic rhinitis in Japanese patients.

Masuyama K, Goto M, Takeno S, Ohta N, Okano M, Kamijo A, Suzuki M, Terada T, Sakurai D, Horiguchi S, Honda K, Matsune S, Yamada T, Sakashita M, Yuta A, Fuchiwaki T, Miyanohara I, Nakayama T, Okamoto Y, Fujieda S.

Auris Nasus Larynx. 2016 Feb;43(1):1-9. doi: 10.1016/j.anl.2015.08.015. Epub 2015 Nov 23. Review.

PMID:
26615715
10.

An evidence-based analysis of house dust mite allergen immunotherapy: a call for more rigorous clinical studies.

Calderon MA, Casale TB, Nelson HS, Demoly P.

J Allergy Clin Immunol. 2013 Dec;132(6):1322-36. doi: 10.1016/j.jaci.2013.09.004. Epub 2013 Oct 18. Review.

PMID:
24139829
11.

GUIDE TO ALLERGEN IMMUNOTHERAPY FOR MITE ALLERGY.

Gotoh M.

Arerugi. 2017;66(6):788-791. doi: 10.15036/arerugi.66.788. Japanese. No abstract available. Erratum in: Arerugi. 2017;66(7):960.

PMID:
28701643
12.

A comparison of immunotherapy delivery methods for allergen immunotherapy.

Klimek L, Pfaar O.

Expert Rev Clin Immunol. 2013 May;9(5):465-74; quiz 475. doi: 10.1586/eci.13.25. Review.

PMID:
23634740
13.

Variation in allergen content in sublingual allergen immunotherapy with house dust mites.

Moreno Benítez F, Espinazo Romeu M, Letrán Camacho A, Mas S, García-Cózar FJ, Tabar AI.

Allergy. 2015 Nov;70(11):1413-20. doi: 10.1111/all.12694. Epub 2015 Sep 11. Review.

14.

Recommendations for appropriate sublingual immunotherapy clinical trials.

Casale TB, Canonica GW, Bousquet J, Cox L, Lockey R, Nelson HS, Passalacqua G.

J Allergy Clin Immunol. 2009 Oct;124(4):665-70. doi: 10.1016/j.jaci.2009.07.054. Epub 2009 Sep 19. Review.

PMID:
19766297
15.

Oral/sublingual Phleum pretense grass tablet (Grazax/Grastek) to treat allergic rhinitis in the USA.

Nelson HS.

Expert Rev Clin Immunol. 2014 Nov;10(11):1437-51. doi: 10.1586/1744666X.2014.963556. Review.

PMID:
25340426
16.

[YEAR IN REVIEW OF NASAL ALLERGY: SUBLINGUAL IMMUNOTHERAPY].

Masuyama K.

Arerugi. 2015 Sep;64(9):1210-4. doi: 10.15036/arerugi.64.1210. Review. Japanese. No abstract available.

PMID:
26657909
17.

Ranking in importance of allergen extract characteristics for sublingual immunotherapy by Italian specialists.

Canonica GW, Passalacqua G, Incorvaia C, Cadario G, Fiocchi A, Senna G, Rossi O, Romano A, Scala E, Romano C, Ingrassia A, Zambito M, Dell'Albani I, Frati F.

Allergy Asthma Proc. 2014 Jan-Feb;35(1):43-6. doi: 10.2500/aap.2013.34.3721.

PMID:
24433596
18.

Safety of sublingual immunotherapy in children.

Frati F, Ridolo E, Fuiano N, Barberi S, Dell'Albani I, Landi M, Ricciardi L, Scala G, Incorvaia C.

Expert Opin Drug Saf. 2014 Jul;13(7):947-53. doi: 10.1517/14740338.2014.918949. Epub 2014 May 12. Review.

PMID:
24821477
19.

[Update on current care guidelines: Allergen specific immunotherapy].

Valovirta E, Korhonen K, Kuitunen M, Kukkonen-Harjula K, Lammintausta K, Pallasaho P, Ralli P, Savolainen J, Toskala E, Virtanen T.

Duodecim. 2012;128(1):108-9. Review. Finnish.

PMID:
22312833
20.

Immune mechanisms of allergen-specific sublingual immunotherapy.

Moingeon P, Batard T, Fadel R, Frati F, Sieber J, Van Overtvelt L.

Allergy. 2006 Feb;61(2):151-65. Review.

PMID:
16409190

Supplemental Content

Support Center